Niagen Bioscience (NAGE) Assets (2011 - 2026)
Niagen Bioscience (NAGE) posted quarterly Assets of $114.3 million for Q1 2026, up 40.56% year-over-year from $81.3 million in Q1 2025, and up 7.45% quarter-over-quarter from $106.4 million in Q4 2025.
Niagen Bioscience (NAGE) Assets (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Assets for 14 consecutive years, with $114.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 40.56% year-over-year to $114.3 million; the TTM figure through Mar 2026 stood at $114.3 million (up 40.56% YoY), while the FY2025 annual figure was $106.4 million, up 55.84% from the prior year.
- Assets improved to $114.3 million in Q1 2026 per NAGE's latest filing, from $106.4 million in the prior quarter.
- Across five years, Assets topped out at $114.3 million in Q1 2026 and bottomed at $45.7 million in Q3 2022.
- Historically, Assets has averaged $67.0 million across 5 years, with a median of $54.1 million in 2024.
- Annual changes were most pronounced in 2022 — Assets dropped 29.2% — and 2025, when it surged 73.63%.
- Niagen Bioscience's Assets stood at $54.1 million in 2022, then grew by 1.68% to $55.0 million in 2023, then advanced by 24.22% to $68.3 million in 2024, then jumped by 55.84% to $106.4 million in 2025, then rose by 7.45% to $114.3 million in 2026.
- Business Quant data shows NAGE's Assets at $114.3 million in Q1 2026, $106.4 million in Q4 2025, and $98.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 106.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.59 Mn |
| Mar 31, 2026 | 114.33 Mn |
| Dec 31, 2025 | 106.41 Mn |
| Sep 30, 2025 | 98.14 Mn |
| Jun 30, 2025 | 91.53 Mn |
| Mar 31, 2025 | 81.34 Mn |
| Dec 31, 2024 | 68.28 Mn |
| Sep 30, 2024 | 56.52 Mn |
| Jun 30, 2024 | 54.04 Mn |
| Mar 31, 2024 | 54.08 Mn |
| Dec 31, 2023 | 54.96 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 53.17 Mn |
| Mar 31, 2023 | 53.77 Mn |
| Dec 31, 2022 | 54.06 Mn |
| Sep 30, 2022 | 45.67 Mn |
| Jun 30, 2022 | 46.61 Mn |
| Mar 31, 2022 | 52.93 Mn |
| Dec 31, 2021 | 57.84 Mn |
| Sep 30, 2021 | 60.45 Mn |